cancer of other GI organs	metastasizes to	liver
cancer of other GI organs	metastasizes to	peritoneum
cancer of other GI organs	metastasizes to	lung
cancer of other GI organs	metastasizes to	bone
cancer of other GI organs	metastasizes to	brain
cancer of other GI organs	metastasizes to	adrenal gland
cancer of other GI organs	metastasizes to	kidney
cancer of other GI organs	metastasizes to	spleen
cancer of other GI organs	metastasizes to	ovary
cancer of other GI organs	metastasizes to	lymph nodes
liver metastasis	worsens	prognosis
peritoneal metastasis	worsens	prognosis
brain metastasis	worsens	prognosis
lung metastasis	worsens	prognosis
bone metastasis	worsens	prognosis
liver metastasis	increases	mortality
peritoneal metastasis	increases	mortality
brain metastasis	increases	mortality
lung metastasis	increases	mortality
bone metastasis	increases	mortality
peritoneal carcinomatosis	presents with	ascites
ascites	causes	abdominal distension
carcinoembryonic antigen	is biomarker for	cancer of other GI organs
carbohydrate antigen 19-9	is biomarker for	cancer of other GI organs
carcinoembryonic antigen	monitors	disease activity
staging	determines	prognosis
TNM staging	guides	treatment decisions
endoscopy	enables	biopsy
biopsy	confirms	cancer of other GI organs
CT scan	detects	peritoneal metastasis
PET-CT	detects	metastasis
MRI	assesses	peritoneum
laparoscopy	aids	staging of cancer of other GI organs
cytoreductive surgery	indicated for	peritoneal metastasis
HIPEC	used for	peritoneal metastasis
chemotherapy	used to treat	cancer of other GI organs
radiation therapy	used to treat	cancer of other GI organs
targeted therapy	used to treat	cancer of other GI organs
immunotherapy	investigated for	cancer of other GI organs
palliative care	integrated with	cancer treatment
nutritional support	needed for	cancer of other GI organs
weight loss	predicts	mortality
anemia	indicates	advanced disease
thrombocytosis	correlates with	tumor burden
neutropenia	results from	chemotherapy
stent placement	relieves	obstruction
bowel obstruction	results from	cancer of other GI organs
malnutrition	worsens	treatment tolerance
sarcopenia	reduces	physical function
quality of life	improves with	palliative care
advanced cancer of other GI organs	associated with	mortality
obstruction	leads to	hospitalization
hospitalization	required for	complication management
surgery	carries	complication risk
cytoreductive surgery	requires	specialized center
HIPEC	requires	multidisciplinary team
malabsorption	results in	nutritional deficiency
thrombosis	associated with	cancer of other GI organs
cachexia	correlates with	poor prognosis
diarrhea	common symptom in	cancer of other GI organs
constipation	common symptom in	cancer of other GI organs
fatigue	common symptom in	advanced cancer
weight loss	hallmark of	cancer of other GI organs
nausea	indicates	cancer of other GI organs
vomiting	indicates	cancer of other GI organs
abdominal pain	is symptom of	cancer of other GI organs
jaundice	occurs with	liver metastasis
portal hypertension	occurs with	liver metastasis
hepatomegaly	accompanies	liver metastasis
peritoneal thickening	seen with	peritoneal carcinomatosis
peritoneal fluid	contains	tumor cells
portal vein invasion	indicates	advanced tumor
neutrophil to lymphocyte ratio	prognostic for	cancer of other GI organs
albumin	reflects	nutritional status
hypoalbuminemia	associated with	poor prognosis
performance status	influences	treatment options
ECOG score	assesses	functional status
functional status	predicts	survival
peritoneal fluid cytology	indicates	peritoneal metastasis
tumor burden	indicates	prognosis
overall survival	is endpoint of	clinical trials
progression-free survival	is endpoint of	clinical trials
response rate	measures	tumor shrinkage
tumor shrinkage	indicates	treatment efficacy
metastatic pattern	informs	prognosis
intraperitoneal chemotherapy	used for	peritoneal metastasis
intraperitoneal chemotherapy	combined with	cytoreductive surgery
colon cancer	is a type of	cancer of other GI organs
small bowel cancer	is a type of	cancer of other GI organs
rectal cancer	is a type of	cancer of other GI organs
peritoneal metastasis	triggers	weight loss
advanced disease	limits	surgical options
hypercoagulability	associated with	cancer of other GI organs
treatment tolerance	depends on	nutritional status
postoperative recovery	affects	hospital length of stay
hospital length of stay	increases with	postoperative complications
surgical margins	determine	local recurrence
local recurrence	worsens	prognosis
palliative chemotherapy	aims to	relieve symptoms
intraperitoneal chemotherapy	provides	local tumor control
